QMENTA News

Contrast enhanced imaging

Contrast enhanced imaging

By Paulo Rodrigues | Neuro Oncology, FDA cleared

T1 weighted imaging pre-post contrast Delta T1 quantification differentiates perfused and non-perfused regions of tumor tissue and allows for monitoring of tumor changes in patients treated with...

QMENTA appoints Rob Bancroft as New Chief Executive Officer.

QMENTA appoints Rob Bancroft as New Chief Executive Officer.

By Paulo Rodrigues | Press Release

QMENTA Appoints Rob Bancroft as New Chief Executive Officer  Paulo Rodrigues Takes the Helm as Chief Technology Officer    Barcelona, Spain. Release: January 22, 2020. For Immediate Release.  QMENTA,...

Top 5 Imaging Trends From ECTRIMS 2019

Top 5 Imaging Trends From ECTRIMS 2019

By Paulo Rodrigues | Expertise

Top 5 Imaging Trends From ECTRIMS 2019 by Pablo Villoslada, MD, PhD.   The world’s largest meeting on Multiple Sclerosis, ECTRIMS 2019, took place in Stockholm, Sweden. This article reviews the major...

QMENTA hosts IronTract Challenge with Harvard

QMENTA hosts IronTract Challenge with Harvard

By Paulo Rodrigues | News

QMENTA is pleased to be collaborating with Harvard’s the Athinoula A. Martinos Center for Biomedical Imaging and the University of Rochester in supporting an exciting research challenge open to image...

QMENTA receives ISO 13485:2016 certification for its QMS system

QMENTA receives ISO 13485:2016 certification for its QMS system

By Paulo Rodrigues | News

      QMENTA’s Quality Management System (QMS) is a company-wide new initiative, which has enhanced the quality of our products & services and improved our system on patient safety. We have...

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

QMENTA appoints Pablo Villoslada, MD, PhD Chief Medical Officer

By Paulo Rodrigues | News

BOSTON, MA, February 6th 2019 – QMENTA – the data-driven, AI-powered company, that aims to revolutionize the way medical imaging is used in clinical trials and clinical care – welcomes Pablo...

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona

By Paulo Rodrigues | News

We are proud to announce that we will be exhibiting at: ECTRIMS in Berlin from October 10th to October 12th, booth C12 RSNA in Chicago from November 25th to November 30th, booth 7665 PCT in Barcelona...

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

QMENTA will provide Data Management and Analysis Services for Amylyx PEGASUS Clinical Trial of AMX0035 for Alzheimer’s Disease

By Paulo Rodrigues | News

BOSTON, MA & CAMBRIDGE, MA – QMENTA and Amylyx Pharmaceuticals today announced a collaboration to support Amylyx’s upcoming clinical trial of AMX0035 in Alzheimer’s disease. QMENTA will use its...

Early Signs of Brain Ischemia on CT and MR; Can AI Lend a Helping Hand?

Early Signs of Brain Ischemia on CT and MR; Can AI Lend a Helping Hand?

By Paulo Rodrigues | Expertise

A poor functional outcome of stroke patients may be predicted by early signs on CT and MRI. Radiology exams carried out within 6 hours after stroke onset can contain important insights supporting the...

How Deep Learning and Neuroimaging Can Improve Diagnosis in Psychiatric Diseases

How Deep Learning and Neuroimaging Can Improve Diagnosis in Psychiatric Diseases

By Paulo Rodrigues | Expertise

Impact of psychiatric disorders in the world. The World Health Organization estimates that around 450 million people suffer from psychiatric disorders. They predict that one in four people in the...